The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease in Slovenia: An Umbrella Review and Economic Evaluation.

Analysis of FDA’s Adverse Event Reporting System (FAERS) database (2014–2023) identified 1270 reports of FCM-associated hypophosphatemia, with an increasing trend over time, though the authors estimated that <1% of actual cases had been reported.

also in 63,971 other papers